Platelet Rich Plasma is one of 668 biologic programs targeting Plantar Fasciitis. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2828 competitors in Breast Cancer
Platelet Rich Plasma
Trodelvy
Cymbalta
Zinecard
Effexor
Acupan
Chantix
Aquasol E
Paracetamol
Perflutren Lipid Microsphere
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details